Benefits and Harmful Effects of Inflammation: Protection, Resolution, Tissue Injury and Organ Failure

Learning outcomes

• Explain the protective benefits of local and systemic inflammation.
• Describe how neutrophils, macrophages, complement, antibodies, fibrin and cytokines cooperate.
• Explain harmful effects including oedema, bystander injury, thrombosis, fibrosis, adhesions, pain, fever and systemic shock.
• Describe resolution as an active process and identify reasons it fails.
• Balance antimicrobial/anti-inflammatory treatment in emergencies.
• Apply the concepts to sepsis, anaphylaxis, infarction, asthma, autoimmune disease and chronic inflammation.

1. Protective benefits

1.1 Recognition and containment

Pattern-recognition receptors detect pathogens and tissue damage. Vasodilation and increased permeability deliver plasma proteins, antibodies and complement. Fibrin and oedema can wall off a local focus, reducing spread through tissue planes and lymphatics.

1.2 Elimination of pathogens

• Opsonisation: complement C3b, antibodies and collectins coat microbes for phagocytosis.
• Phagocytosis: neutrophils and macrophages engulf organisms and debris.
• Oxidative killing: the respiratory burst produces superoxide, hydrogen peroxide and hypochlorous acid.
• Non-oxidative killing: lysosomal enzymes, defensins, lactoferrin and low pH damage microbes.
• Extracellular traps: neutrophil chromatin can immobilise organisms, although excessive NETs injure endothelium.
• Adaptive coordination: T cells and antibodies provide specificity and memory.

1.3 Removal of dead tissue and foreign material

Macrophages recognise apoptotic cells and necrotic debris, digest them and transport soluble material through lymphatics. This clears the field for regeneration or scar formation.

1.4 Initiation of repair

Macrophages, platelets, endothelial cells and fibroblasts release growth factors. Angiogenesis restores oxygen, fibroblasts deposit matrix and epithelial cells migrate over a wound. Controlled inflammation therefore prepares tissue reconstruction.

1.5 Systemic coordination

Fever can inhibit some pathogens and enhance immune reactions. The liver produces CRP, complement and fibrinogen; bone marrow releases leukocytes; iron is sequestered through hepcidin. These changes support host defence but become harmful when severe or prolonged.

2. How inflammation causes tissue injury

2.1 Bystander damage from leukocytes

Activated neutrophils and macrophages cannot always distinguish microbes from adjacent host tissue. ROS, proteases, elastase, myeloperoxidase products, NETs and cytokines destroy extracellular matrix, epithelium, endothelium and parenchymal cells.

2.2 Oedema and pressure

Protein-rich exudate increases tissue volume and interstitial pressure. In the brain, lungs, airways, renal tubules and closed fascial compartments, oedema compromises perfusion or ventilation.

2.3 Thrombosis and microvascular obstruction

Activated endothelium expresses tissue factor and adhesion molecules. Platelets, NETs and fibrin form microthrombi that worsen ischaemia. This is important in sepsis, COVID-like viral inflammation, vasculitis and atherosclerotic plaque rupture.

2.4 Pain and loss of function

Bradykinin, prostaglandins, ATP and nerve compression sensitise nociceptors. Pain limits movement and protects the injured region but can produce immobility, atelectasis and deconditioning when prolonged.

3. Local harmful effects

Effect	Mechanism	Possible consequence
Persistent swelling	Permeability, sodium/water retention and lymphatic overload.	Compartment syndrome, airway obstruction or nerve compression.
Suppuration	Neutrophil enzymes digest tissue and form pus.	Abscess, fistula, bacteraemia and scarring.
Ulceration	Surface necrosis and loss of epithelium.	Bleeding, perforation and impaired absorption.
Fibrosis	Persistent macrophage/TGF-β signalling activates fibroblasts.	Strictures, adhesions, cirrhosis or lung fibrosis.
Thrombosis	Endothelial activation and platelet–leukocyte interaction.	Ischaemia, infarction or embolism.
Destruction of specialised tissue	ROS, proteases and cytotoxic lymphocytes.	Loss of neurons, nephrons, beta cells or myocytes.

4. Systemic harmful effects

4.1 Fever and metabolic stress

IL-1, TNF and prostaglandin E₂ reset the hypothalamic temperature set point. Fever increases metabolic rate, oxygen demand and insensible fluid loss. It can worsen myocardial ischaemia, delirium or seizures in vulnerable patients.

4.2 Acute-phase and haematologic effects

IL-6 induces CRP and fibrinogen; hepcidin sequesters iron; thrombopoietin and marrow signals change blood counts. Chronic inflammation produces anaemia of inflammation, thrombocytosis and cachexia.

4.3 Hypotension and shock

TNF, IL-1, nitric oxide and endothelial injury cause vasodilation and capillary leak. Plasma leaves the circulation, venous return falls and microvascular perfusion becomes heterogeneous. Severe dysregulation produces septic or cytokine-mediated shock.

4.4 Acute respiratory distress

Neutrophils and endothelial injury disrupt the alveolar–capillary barrier. Protein-rich fluid fills alveoli, reducing compliance and oxygenation. Mechanical ventilation and fluid strategy must be carefully balanced.

4.5 Disseminated coagulation

Inflammatory tissue factor, platelet activation and endothelial damage can consume clotting factors and platelets while producing microthrombi. Bleeding and organ ischaemia may coexist.

4.6 Multi-organ dysfunction

Persistent cytokines, hypoperfusion, microthrombi and mitochondrial dysfunction injure kidneys, liver, brain, heart and lungs. The clinical trajectory depends on early source control and restoration of perfusion.

5. Resolution: an active biological programme

Resolution is not simply “inflammation running out.” It requires coordinated termination and repair.

1. Remove or neutralise the inciting stimulus.
2. Stop recruitment signals and degrade short-lived mediators.
3. Neutrophils undergo apoptosis rather than releasing further enzymes.
4. Macrophages perform efferocytosis and switch toward pro-resolution functions.
5. Lymphatics drain protein-rich oedema and debris.
6. Lipoxins, resolvins, protectins, maresins, IL-10 and TGF-β restrain further leukocyte recruitment.
7. Regeneration restores tissue when the matrix and stem-cell reserve are intact; otherwise fibrosis provides structural closure.

5.1 Why resolution fails

• Persistent infection or biofilm.
• Retained foreign body or crystal.
• Ongoing toxin, smoking or metabolic stress.
• Defective efferocytosis or lymphatic drainage.
• Repeated injury and poor perfusion.
• Autoimmune stimulation and failure of tolerance.

6. Benefits and harms by clinical setting

Setting	Protective benefit	Potential harm
Pneumonia	Neutrophils and antibodies remove organisms.	Alveolar leak, ARDS and fibrosis.
Myocardial infarction	Macrophages clear necrotic myocytes and initiate scar.	Peri-infarct injury, arrhythmia, ventricular rupture.
Anaphylaxis	Rapid defence against a perceived allergen.	Airway oedema, bronchospasm and shock.
Gout	Crystals are recognised and cleared.	Severe sterile synovitis and joint damage.
Wound healing	Debris removal and repair signalling.	Hypertrophic scar, keloid or chronic ulcer.
Autoimmunity	Normally protects against infection.	Persistent self-tissue destruction.

7. Anti-inflammatory treatment: preserve benefit, limit harm

Intervention	Benefit	Risk or limitation
Antimicrobials	Remove infectious stimulus.	Resistance, allergy, microbiome injury; do not replace source control.
NSAIDs	Reduce prostaglandin-mediated pain, fever and swelling.	GI bleeding, kidney injury, hypertension and cardiovascular risk.
Corticosteroids	Suppress cytokines, leukocyte migration and immune injury.	Hyperglycaemia, infection, delirium and impaired healing.
Adrenaline in anaphylaxis	Reverses vasodilation, bronchospasm and oedema.	Arrhythmia or hypertension if misused; benefits far outweigh risk in true anaphylaxis.
Source control	Removes abscess, necrotic tissue, obstruction or foreign body.	Requires procedural/surgical expertise and timing.
Organ support	Maintains oxygenation, perfusion and metabolism while cause is treated.	Ventilator, fluid and vasopressor complications require monitoring.

Never use anti-inflammatory medication as a substitute for identifying the cause. Immunosuppression can worsen occult infection; withholding needed therapy can allow irreversible organ injury.

8. Emergency applications

• Anaphylaxis: inflammation is immediately life-threatening; give intramuscular adrenaline and support airway/breathing/circulation.
• Sepsis: treat infection and source, assess perfusion and support failing organs rather than focusing only on CRP or fever.
• Acute asthma: control bronchoconstriction and airway inflammation while recognising fatigue and impending respiratory failure.
• Raised intracranial pressure: inflammatory oedema can cause herniation; protect airway, optimise oxygen/ventilation and seek neurosurgical care.
• Compartment syndrome: swelling within a closed space compromises perfusion; urgent surgical assessment is required.
• Burns and trauma: inflammation is necessary for repair but excessive oedema and systemic response require fluid, airway and temperature management.

9. Applied cases

Case 1: Local abscess

Neutrophils contain infection but liquefy tissue and create a walled-off collection. Antibiotics alone may fail because penetration is poor. Drainage and culture provide source control while monitoring for sepsis.

Case 2: Severe sepsis

TNF, IL-1, nitric oxide, endothelial leak and microthrombi produce hypotension and organ dysfunction. The inflammatory response is no longer protective because it is dysregulated and systemic. Treat the infection rapidly and reassess perfusion and organ function serially.

Case 3: Autoimmune flare

Inflammation protects against pathogens but is misdirected against self tissue. Immunomodulation may be lifesaving, but infection must be considered before escalating therapy.

10. Quick self-test

1. List three benefits of inflammation.
   Answer: Containment, microbial killing, debris removal and initiation of repair (any three).
2. How can neutrophils damage host tissue?
   Answer: ROS, proteases, elastase, myeloperoxidase products and NETs injure bystander cells and matrix.
3. Why can oedema become dangerous?
   Answer: It raises tissue pressure, compromises perfusion, impairs gas exchange or obstructs an airway.
4. What is resolution?
   Answer: Active termination of mediator signalling, clearance of leukocytes/debris, lymphatic drainage and restoration or repair of tissue.
5. Give two reasons inflammation fails to resolve.
   Answer: Persistent infection, foreign body, crystal, toxin, autoimmune stimulation or defective clearance.
6. Why is source control essential?
   Answer: Removing an abscess, necrotic focus, obstruction or foreign body eliminates the continuing inflammatory stimulus.
7. What is the first-line drug in anaphylaxis?
   Answer: Intramuscular adrenaline.
8. Why can corticosteroids be dangerous in infection?
   Answer: They suppress protective immune responses and can worsen uncontrolled infection or delay healing.

11. Take-home summary

Selected references

• NCBI Bookshelf: Inflammation and Repair
• NCBI Bookshelf: Acute Inflammation
• NCBI Bookshelf: Sepsis and Septic Shock
• NCBI Bookshelf: Anaphylaxis

Educational note: This resource supports learning and clinical reasoning. Current local protocols, senior supervision and national guidelines take precedence in patient care.